Literature DB >> 19258309

Defects in transient tRNA translocation bypass tRNA synthetase quality control mechanisms.

Rachel A Hellmann1, Susan A Martinis.   

Abstract

Quality control mechanisms during protein synthesis are essential to fidelity and cell survival. Leucyl-tRNA synthetase (LeuRS) misactivates non-leucine amino acids including isoleucine, methionine, and norvaline. To prevent translational errors, mischarged tRNA products are translocated 30A from the canonical aminoacylation core to a hydrolytic editing-active site within a completely separate domain. Because it is transient, the tRNA translocation mechanism has been difficult to isolate. We have identified a "translocation peptide" within Escherichia coli LeuRS. Mutations in the translocation peptide cause tRNA to selectively bypass the editing-active site, resulting in mischarging that is lethal to the cell. This bypass mechanism also rescues aminoacylation of an editing site mutation that hydrolyzes correctly charged Leu-tRNA(Leu). Thus, these LeuRS mutants charge tRNA(Leu) but fail to translocate these products to the hydrolytic site, where they are cleared to guard against genetic code ambiguities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19258309      PMCID: PMC2670153          DOI: 10.1074/jbc.M807395200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  The morph server: a standardized system for analyzing and visualizing macromolecular motions in a database framework.

Authors:  W G Krebs; M Gerstein
Journal:  Nucleic Acids Res       Date:  2000-04-15       Impact factor: 16.971

2.  A conserved threonine within Escherichia coli leucyl-tRNA synthetase prevents hydrolytic editing of leucyl-tRNALeu.

Authors:  R S Mursinna; T L Lincecum; S A Martinis
Journal:  Biochemistry       Date:  2001-05-08       Impact factor: 3.162

3.  Structural and mechanistic basis of pre- and posttransfer editing by leucyl-tRNA synthetase.

Authors:  Tommie L Lincecum; Michael Tukalo; Anna Yaremchuk; Richard S Mursinna; Amy M Williams; Brian S Sproat; Wendy Van Den Eynde; Andreas Link; Serge Van Calenbergh; Morten Grøtli; Susan A Martinis; Stephen Cusack
Journal:  Mol Cell       Date:  2003-04       Impact factor: 17.970

4.  Interstice mutations that block site-to-site translocation of a misactivated amino acid bound to a class I tRNA synthetase.

Authors:  Anthony C Bishop; Kirk Beebe; Paul R Schimmel
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-06       Impact factor: 11.205

5.  Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration.

Authors:  Jeong Woong Lee; Kirk Beebe; Leslie A Nangle; Jaeseon Jang; Chantal M Longo-Guess; Susan A Cook; Muriel T Davisson; John P Sundberg; Paul Schimmel; Susan L Ackerman
Journal:  Nature       Date:  2006-08-13       Impact factor: 49.962

6.  Evidence for the double-sieve editing mechanism in protein synthesis. Steric exclusion of isoleucine by valyl-tRNA synthetases.

Authors:  A R Fersht; C Dingwall
Journal:  Biochemistry       Date:  1979-06-12       Impact factor: 3.162

7.  Transfer ribonucleic acid synthetase catalyzed deacylation of aminoacyl transfer ribonucleic acid in the absence of adenosine monophosphate and pyrophosphate.

Authors:  A A Schreier; P R Schimmel
Journal:  Biochemistry       Date:  1972-04-25       Impact factor: 3.162

8.  Isolation and partial characterization of temperature-sensitive Escherichia coli mutants with altered leucyl- and seryl-transfer ribonucleic acid synthetases.

Authors:  B Low; F Gates; T Goldstein; D Söll
Journal:  J Bacteriol       Date:  1971-11       Impact factor: 3.490

9.  Structural basis for double-sieve discrimination of L-valine from L-isoleucine and L-threonine by the complex of tRNA(Val) and valyl-tRNA synthetase.

Authors:  S Fukai; O Nureki; S Sekine; A Shimada; J Tao; D G Vassylyev; S Yokoyama
Journal:  Cell       Date:  2000-11-22       Impact factor: 41.582

10.  Molecular modeling study of the editing active site of Escherichia coli leucyl-tRNA synthetase: two amino acid binding sites in the editing domain.

Authors:  Keun Woo Lee; James M Briggs
Journal:  Proteins       Date:  2004-03-01
View more
  8 in total

Review 1.  Stress Response and Adaptation Mediated by Amino Acid Misincorporation during Protein Synthesis.

Authors:  Xiaoyun Wang; Tao Pan
Journal:  Adv Nutr       Date:  2016-07-15       Impact factor: 8.701

2.  Characterization of benzoxaborole-based antifungal resistance mutations demonstrates that editing depends on electrostatic stabilization of the leucyl-tRNA synthetase editing cap.

Authors:  Jaya Sarkar; Weimin Mao; Tommie L Lincecum; M R K Alley; Susan A Martinis
Journal:  FEBS Lett       Date:  2011-08-16       Impact factor: 4.124

3.  Coordination of tRNA synthetase active sites for chemical fidelity.

Authors:  Michal T Boniecki; Susan A Martinis
Journal:  J Biol Chem       Date:  2012-02-13       Impact factor: 5.157

Review 4.  The balance between pre- and post-transfer editing in tRNA synthetases.

Authors:  Susan A Martinis; Michal T Boniecki
Journal:  FEBS Lett       Date:  2010-01-21       Impact factor: 4.124

5.  A paradigm shift for the amino acid editing mechanism of human cytoplasmic leucyl-tRNA synthetase.

Authors:  Yan Ling Joy Pang; Susan A Martinis
Journal:  Biochemistry       Date:  2009-09-29       Impact factor: 3.162

6.  A glycine hinge for tRNA-dependent translocation of editing substrates to prevent errors by leucyl-tRNA synthetase.

Authors:  Anjali P Mascarenhas; Susan A Martinis
Journal:  FEBS Lett       Date:  2009-09-29       Impact factor: 4.124

Review 7.  tRNA synthetase: tRNA aminoacylation and beyond.

Authors:  Yan Ling Joy Pang; Kiranmai Poruri; Susan A Martinis
Journal:  Wiley Interdiscip Rev RNA       Date:  2014-04-04       Impact factor: 9.957

8.  Translational fidelity maintenance preventing Ser mis-incorporation at Thr codon in protein from eukaryote.

Authors:  Xiao-Long Zhou; Zhi-Rong Ruan; Qian Huang; Min Tan; En-Duo Wang
Journal:  Nucleic Acids Res       Date:  2012-10-23       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.